Establishment and characterization of an iPSC line from a 58 years old high grade patient with nonalcoholic fatty liver disease (70% steatosis) with homozygous wildtype PNPLA3 genotype
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and its prevalence increases continuously. Here, we reprogrammed fibroblasts of a high grade NAFLD patient with homozygous wildtype PNPLA3 genotype. We characterized the induced pluripotent stem cells (iPSCs) by immunocytochemistry, flow cytometry, embryoid body formation, pluritest DNA-fingerprinting, and karyotype analysis. Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.
|Authors||Graffmann N, Bohndorf M, Ncube A, Wruck W, Kashofer K, Zatloukal K, Adjaye J|
|Journal||Stem cell research|
|Publication Date||2018 Aug;31:131-134|